| Primary |
| Product Used For Unknown Indication |
49.2% |
| Essential Thrombocythaemia |
31.3% |
| Thrombocytosis |
5.1% |
| Hypertension |
3.0% |
| Myelofibrosis |
1.3% |
| Bronchitis |
1.0% |
| Myeloproliferative Disorder |
1.0% |
| Prophylaxis |
1.0% |
| Thrombocytopenia |
1.0% |
| Bronchitis Chronic |
0.7% |
| Chronic Obstructive Pulmonary Disease |
0.7% |
| Diabetes Mellitus |
0.7% |
| Peripheral Arterial Occlusive Disease |
0.7% |
| Pulmonary Embolism |
0.7% |
| Renal Failure |
0.7% |
| Thrombosis |
0.7% |
| Angina Pectoris |
0.3% |
| Anxiety Disorder |
0.3% |
| Arrhythmia |
0.3% |
| Atrial Fibrillation |
0.3% |
|
| Myelofibrosis |
10.9% |
| Breast Cancer |
6.5% |
| Coronary Artery Disease |
6.5% |
| Gastrointestinal Haemorrhage |
6.5% |
| Myocardial Infarction |
6.5% |
| Rectal Haemorrhage |
6.5% |
| Thrombocytopenia |
6.5% |
| Hospitalisation |
4.3% |
| Hypertension |
4.3% |
| Palpitations |
4.3% |
| Platelet Count Increased |
4.3% |
| Pulmonary Oedema |
4.3% |
| Skin Ulcer |
4.3% |
| Splenic Vein Thrombosis |
4.3% |
| Syncope |
4.3% |
| Transient Ischaemic Attack |
4.3% |
| Vomiting |
4.3% |
| Acute Coronary Syndrome |
2.2% |
| Acute Myocardial Infarction |
2.2% |
| Angina Pectoris |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
33.2% |
| Essential Thrombocythaemia |
20.1% |
| Hypertension |
11.7% |
| Breast Cancer |
7.0% |
| Thrombocytosis |
4.2% |
| Hypercholesterolaemia |
3.4% |
| Myelofibrosis |
2.1% |
| Prostate Cancer |
2.1% |
| Drug Use For Unknown Indication |
1.8% |
| Bronchitis Chronic |
1.6% |
| Embolic Stroke |
1.6% |
| Prophylaxis |
1.6% |
| Thromboembolic Stroke |
1.6% |
| Thrombosis |
1.6% |
| Breast Cancer Female |
1.3% |
| Cerebrovascular Accident |
1.0% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Osteoporosis Prophylaxis |
1.0% |
| Peripheral Arterial Occlusive Disease |
1.0% |
| Thrombocythaemia |
1.0% |
|
| Renal Failure |
12.7% |
| Palpitations |
10.9% |
| Oesophagitis |
7.3% |
| Transient Ischaemic Attack |
7.3% |
| Lung Infection |
5.5% |
| Malignant Neoplasm Progression |
5.5% |
| Skin Ulcer |
5.5% |
| Tachycardia |
5.5% |
| Ventricular Extrasystoles |
5.5% |
| White Blood Cell Count Decreased |
5.5% |
| Acute Coronary Syndrome |
3.6% |
| Acute Myeloid Leukaemia |
3.6% |
| Pancytopenia |
3.6% |
| Pulmonary Arterial Hypertension |
3.6% |
| Syncope |
3.6% |
| Viral Infection |
3.6% |
| Asthenia |
1.8% |
| Bronchioloalveolar Carcinoma |
1.8% |
| Cerebral Haemorrhage |
1.8% |
| Condition Aggravated |
1.8% |
|
| Concomitant |
| Bipolar Disorder |
17.6% |
| Chronic Myeloid Leukaemia |
11.8% |
| Essential Thrombocythaemia |
11.8% |
| Autoimmune Thyroiditis |
5.9% |
| Bipolar I Disorder |
5.9% |
| Cardiovascular Disorder |
5.9% |
| Hepatitis B |
5.9% |
| Hypertension |
5.9% |
| Interstitial Lung Disease |
5.9% |
| Mania |
5.9% |
| Myelofibrosis |
5.9% |
| Thrombocythaemia |
5.9% |
| Thrombocytosis |
5.9% |
|
| Weight Increased |
28.6% |
| Pancreatitis Acute |
14.3% |
| Renal Failure |
14.3% |
| Tachycardia |
14.3% |
| Urinary Retention |
14.3% |
| Vertigo |
14.3% |
|
